Evaluation of second-line apatinib plus irinotecan as a treatment for advanced gastric adenocarcinoma or gastroesophageal conjunction adenocarcinoma: a prospective, multicenter phase II trial
评估二线阿帕替尼联合伊立替康治疗晚期胃腺癌或胃食管交界处腺癌的疗效:一项前瞻性、多中心 II 期试验
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1072943
Qu, Jinglei; He, Xin; Luo, Ying; Yu, Ping; Chen, Ying; Liu, Jing; Wang, Xin; Wang, Chang; Liang, Tingting; Bai, Yuxian; Han, Yu; Man, Li; Leng, Chuanchun; Zhou, Caiyun; He, Lijie; Wang, Xin; Liu, Yunpeng; Qu, Xiujuan